[go: up one dir, main page]

PL2929880T3 - Środek terapeutyczny do leczenia choroby, wykazujący hamujący wpływ na czynnik hamujący migrację makrofagów - Google Patents

Środek terapeutyczny do leczenia choroby, wykazujący hamujący wpływ na czynnik hamujący migrację makrofagów

Info

Publication number
PL2929880T3
PL2929880T3 PL14826811T PL14826811T PL2929880T3 PL 2929880 T3 PL2929880 T3 PL 2929880T3 PL 14826811 T PL14826811 T PL 14826811T PL 14826811 T PL14826811 T PL 14826811T PL 2929880 T3 PL2929880 T3 PL 2929880T3
Authority
PL
Poland
Prior art keywords
disease
treating
factor
therapeutic agent
inhibitory effect
Prior art date
Application number
PL14826811T
Other languages
English (en)
Inventor
Keiichi Tanaka
Kimiko Morimoto
Original Assignee
Toyama Chemical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co., Ltd. filed Critical Toyama Chemical Co., Ltd.
Publication of PL2929880T3 publication Critical patent/PL2929880T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrane Compounds (AREA)
PL14826811T 2013-07-18 2014-07-17 Środek terapeutyczny do leczenia choroby, wykazujący hamujący wpływ na czynnik hamujący migrację makrofagów PL2929880T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2013149690 2013-07-18

Publications (1)

Publication Number Publication Date
PL2929880T3 true PL2929880T3 (pl) 2017-03-31

Family

ID=52346269

Family Applications (2)

Application Number Title Priority Date Filing Date
PL14826811T PL2929880T3 (pl) 2013-07-18 2014-07-17 Środek terapeutyczny do leczenia choroby, wykazujący hamujący wpływ na czynnik hamujący migrację makrofagów
PL16169414T PL3078372T3 (pl) 2013-07-18 2014-07-17 Środek terapeutyczny do leczenia choroby wykazujący hamujące działanie na czynnik hamujący migrację makrofagów

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL16169414T PL3078372T3 (pl) 2013-07-18 2014-07-17 Środek terapeutyczny do leczenia choroby wykazujący hamujące działanie na czynnik hamujący migrację makrofagów

Country Status (22)

Country Link
US (3) US20150353519A1 (pl)
EP (2) EP2929880B1 (pl)
JP (2) JP5802868B2 (pl)
CN (1) CN105407887B (pl)
AU (1) AU2014291149B2 (pl)
CA (1) CA2918325C (pl)
CY (2) CY1118140T1 (pl)
DK (2) DK3078372T3 (pl)
ES (2) ES2642440T3 (pl)
HR (2) HRP20161317T1 (pl)
HU (2) HUE029800T2 (pl)
IL (1) IL243550B (pl)
LT (2) LT3078372T (pl)
NO (1) NO3078372T3 (pl)
PL (2) PL2929880T3 (pl)
PT (2) PT3078372T (pl)
RS (2) RS55394B1 (pl)
RU (2) RU2750540C2 (pl)
SI (2) SI3078372T1 (pl)
SM (3) SMT201700080T1 (pl)
TW (1) TWI603965B (pl)
WO (1) WO2015008827A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11235976B2 (en) * 2017-01-26 2022-02-01 Sichuan Yingrui Pharmaceutical Technology Company Nanocarbon-iron composite system as well as composition, preparation method and use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0753725B2 (ja) 1987-10-08 1995-06-07 富山化学工業株式会社 4h―1―ベンゾピラン―4―オン誘導体およびその塩、それらの製造法並びにそれらを含有する抗炎症剤
EP0695547B1 (en) * 1993-04-09 2001-08-08 Toyama Chemical Co., Ltd. Immunomodulator, cell adhesion inhibitor, and agent for treating and preventing autoimmune diseases
DE59603512D1 (de) * 1995-12-21 1999-12-02 Siemens Ag Luftansaugvorrichtung mit variabler saugrohrlänge für eine brennkraftmaschine
DE10044091A1 (de) * 2000-09-07 2002-04-04 Merck Patent Gmbh Chromanonderivate
GB0507696D0 (en) * 2005-04-15 2005-05-25 Novartis Ag Organic compounds
GB0507695D0 (en) 2005-04-15 2005-05-25 Novartis Ag Organic compounds
WO2007042035A2 (en) * 2005-10-07 2007-04-19 Aditech Pharma Ab Combination therapy with fumaric acid esters for the treatment of autoimmune and/or inflammatory disorders
US9421186B2 (en) 2011-08-30 2016-08-23 Toyama Chemical Co., Ltd. Method for improving therapy for autoimmune diseases such as rheumatoid arthritis

Also Published As

Publication number Publication date
HRP20171497T1 (hr) 2017-11-17
EP3078372A1 (en) 2016-10-12
EP2929880B1 (en) 2016-09-14
HK1222556A1 (zh) 2017-07-07
WO2015008827A1 (ja) 2015-01-22
CN105407887B (zh) 2018-09-04
CY1119496T1 (el) 2018-03-07
AU2014291149B2 (en) 2017-05-04
US20160228406A1 (en) 2016-08-11
PT2929880T (pt) 2016-11-08
US9918963B2 (en) 2018-03-20
EP3078372B1 (en) 2017-09-13
RU2641301C2 (ru) 2018-01-17
SI3078372T1 (en) 2018-01-31
PT3078372T (pt) 2017-10-18
HUE034661T2 (en) 2018-02-28
JP6060231B2 (ja) 2017-01-11
CN105407887A (zh) 2016-03-16
SMT201700080T1 (it) 2017-03-08
RU2017131951A (ru) 2019-02-06
NO3078372T3 (pl) 2018-02-10
DK3078372T3 (en) 2017-10-16
RU2750540C2 (ru) 2021-06-29
HRP20161317T1 (hr) 2016-12-16
ES2593527T3 (es) 2016-12-09
CA2918325C (en) 2018-06-26
TW201536764A (zh) 2015-10-01
RU2017131951A3 (pl) 2020-12-18
CY1118140T1 (el) 2017-06-28
SMT201700080B (it) 2017-03-08
IL243550A0 (en) 2016-02-29
ES2642440T3 (es) 2017-11-16
HUE029800T2 (en) 2017-04-28
SMT201700606T1 (it) 2018-01-11
LT2929880T (lt) 2016-11-25
JP5802868B2 (ja) 2015-11-04
RS56489B1 (sr) 2018-01-31
JPWO2015008827A1 (ja) 2017-03-02
CA2918325A1 (en) 2015-01-22
EP2929880A1 (en) 2015-10-14
JP2016034953A (ja) 2016-03-17
AU2014291149A1 (en) 2016-02-11
RU2016105141A (ru) 2017-08-23
PL3078372T3 (pl) 2018-02-28
IL243550B (en) 2019-06-30
DK2929880T3 (da) 2017-01-02
EP2929880A4 (en) 2015-10-14
RS55394B1 (sr) 2017-04-28
US20150353519A1 (en) 2015-12-10
LT3078372T (lt) 2017-11-27
US20160228404A1 (en) 2016-08-11
SI2929880T1 (sl) 2016-12-30
TWI603965B (zh) 2017-11-01

Similar Documents

Publication Publication Date Title
CY2023027I2 (el) Ενωσεις πυριμιδινοδιονης εναντι καρδιακων παθησεων
EP2958489C0 (de) Ekg-gerät
EP3954536C0 (en) MULTILAYER MATRIX AS TISSUE SUBSTITUTE
HUE046596T2 (hu) Eljárások mitokondriális betegség kezelésére
IL256206A (en) Mct4 inhibitors for treating disease
LT3563837T (lt) Terapija bakteriofagu
BR302014001196S1 (pt) Configuração aplicada em dispositivo médico
LT3046537T (lt) Farmacinis angliavandenių preparatas, skirtas terapiniam panaudojimui
PL2929880T3 (pl) Środek terapeutyczny do leczenia choroby, wykazujący hamujący wpływ na czynnik hamujący migrację makrofagów
BR302014001193S1 (pt) Configuração aplicada em dispositivo médico
BR302014001194S1 (pt) Configuração aplicada em dispositivo médico
BR302014001192S1 (pt) Configuração aplicada em dispositivo médico
FR3005394B1 (fr) Cache oreille.
BR302013000449S1 (pt) Configuração aplicada em piso.
BR302013006606S1 (pt) Configuração aplicada em pé para mobilia.
BR302013006607S1 (pt) Configuração aplicada em pé para mobilia.
BR302013000507S1 (pt) Configuração aplicada em freio hidráulico.
BR302013005932S1 (pt) Configuração aplicada em sapatilha
BR302013005933S1 (pt) Configuração aplicada em sapatilha
BR302013005526S1 (pt) Configuração aplicada em sapatilha
BR302013005288S1 (pt) Configuração aplicada em sapatilha
TH1501000240A (th) องค์ประกอบสำหรับควบคุมโรคพืชและการใช้องค์ประกอบเหล่านั้นสำหรับควบคุมโรคพืช
BR302013004256S1 (pt) Configuração aplicada em sapatilha
BR302013003824S1 (pt) Configuração aplicada em sapatilha
BR302013003628S1 (pt) Configuração aplicada em sapatilha